Oral Health Consequences of Smokeless Tobacco Use

Overview

Journal Indian J Med Res

Specialty General Medicine

Date 2018 Sep 29

PMID 30264752

Citations 44

Authors

Arvind Muthukrishnan

Saman Warnakulasuriya

Affiliations

Soon will be listed here.

Abstract

Smokeless tobacco (SLT) use has many oral effects including oral cancer, leukoplakia and erythroplakia, oral submucous fibrosis (if mixed with areca nut), loss of periodontal support (recession) and staining of teeth and composite restorations. This review was aimed to provide information to identify oral lesions that occur due to the use of smokeless tobacco so that effective interventions can be undertaken to reduce morbidity and mortality from the use of SLT.

Citing Articles

Molecular insight into histone methylation as a novel target for oral squamous cell carcinoma: future hope in personalised medicine.

Rajendran P, Prasad M, Ali E, Sekar R, Alzahrani A, Karobari M J Cancer. 2025; 16(5):1575-1590.

PMID: 39991574 PMC: 11843246. DOI: 10.7150/jca.103243.

Behavioral modification strategies for tobacco cessation: A scoping review.

Vats S, Gupta R, Rajeev A, Gupta B, Sharma D, Mehrotra K J Educ Health Promot. 2025; 13():419.

PMID: 39811861 PMC: 11731225. DOI: 10.4103/jehp.jehp_1790_23.

Community awareness regarding smokeless tobacco (Shamma) as a cause of oral cancer in Jazan region, Saudi Arabia: A cross-sectional study.

Dallak F, Alharbi F, Alhazmi A, Abusageah F, Durayb A, Almalki N J Family Med Prim Care. 2024; 13(11):4885-4893.

PMID: 39722995 PMC: 11668448. DOI: 10.4103/jfmpc.jfmpc_534_24.

Beyond Tobacco: Bridging Gaps in Social History Records for Tobacco-Free Nicotine Pouch Consumers.

Stack T, McCain M, Benaim E, Dickerson T, Mohammad I, Senior B OTO Open. 2024; 8(4):e70034.

PMID: 39534855 PMC: 11555441. DOI: 10.1002/oto2.70034.

Farokhi M, Gelfond J, Khan S, Taverna M, Ali F, Sangdahl C Tex Dent J. 2024; 141(3):128-137.

PMID: 39403272 PMC: 11471871.

References

Axell T, Andersson G, Larsson A . Oral mucosal findings associated with chewing tobacco in Sweden--a clinical and histological study. J Dent Assoc S Afr. 1992; 47(5):194-6. View

. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum. 2005; 85:1-334. PMC: 4781453. View

Gupta P . Mouth cancer in India: a new epidemic?. J Indian Med Assoc. 2000; 97(9):370-3. View

Warnakulasuriya S, Johnson N, van der Waal I . Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007; 36(10):575-80. DOI: 10.1111/j.1600-0714.2007.00582.x. View

Javed F, Chotai M, Mehmood A, Almas K . Oral mucosal disorders associated with habitual gutka usage: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 109(6):857-64. DOI: 10.1016/j.tripleo.2009.12.038. View

Richter P, Hodge K, Stanfill S, Zhang L, Watson C . Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines. Nicotine Tob Res. 2008; 10(11):1645-52. DOI: 10.1080/14622200802412937. View

Guha N, Warnakulasuriya S, Vlaanderen J, Straif K . Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control. Int J Cancer. 2013; 135(6):1433-43. DOI: 10.1002/ijc.28643. View

Gupta P, Ray C . Smokeless tobacco and health in India and South Asia. Respirology. 2004; 8(4):419-31. DOI: 10.1046/j.1440-1843.2003.00507.x. View

Warnakulasuriya S, Dietrich T, Bornstein M, Casals Peidro E, Preshaw P, Walter C . Oral health risks of tobacco use and effects of cessation. Int Dent J. 2010; 60(1):7-30. View

10.

Stepanov I, Hecht S, Ramakrishnan S, Gupta P . Tobacco-specific nitrosamines in smokeless tobacco products marketed in India. Int J Cancer. 2005; 116(1):16-9. DOI: 10.1002/ijc.20966. View

11.

Kramer I, LUCAS R, PINDBORG J, Sobin L . Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978; 46(4):518-39. View

12.

. Personal habits and indoor combustions. IARC Monogr Eval Carcinog Risks Hum. 2012; 100(Pt E):1-538. PMC: 4781577. View

13.

Walsh P, Epstein J . The oral effects of smokeless tobacco. J Can Dent Assoc. 2000; 66(1):22-5. View

14.

Arain S, Kazi T, Afridi H, Talpur F, Kazi A, Brahman K . Correlation of Arsenic Levels in Smokeless Tobacco Products and Biological Samples of Oral Cancer Patients and Control Consumers. Biol Trace Elem Res. 2015; 168(2):287-95. DOI: 10.1007/s12011-015-0355-y. View

15.

Warnakulasuriya S, Ariyawardana A . Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2015; 45(3):155-66. DOI: 10.1111/jop.12339. View

16.

Rekha K, Angadi P . Verrucous carcinoma of the oral cavity: a clinico-pathologic appraisal of 133 cases in Indians. Oral Maxillofac Surg. 2010; 14(4):211-8. DOI: 10.1007/s10006-010-0222-0. View

17.

. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum. 2008; 89:1-592. PMC: 4781254. View

18.

Warnakulasuriya S, Kerr A . Oral submucous fibrosis: a review of the current management and possible directions for novel therapies. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 122(2):232-41. DOI: 10.1016/j.oooo.2016.02.020. View

19.

Walvekar R, Chaukar D, Deshpande M, Pai P, Chaturvedi P, Kakade A . Verrucous carcinoma of the oral cavity: A clinical and pathological study of 101 cases. Oral Oncol. 2008; 45(1):47-51. DOI: 10.1016/j.oraloncology.2008.03.014. View